CN1651088A - Effervescent preparation using alditol as functional ingredient - Google Patents
Effervescent preparation using alditol as functional ingredient Download PDFInfo
- Publication number
- CN1651088A CN1651088A CN 200410021760 CN200410021760A CN1651088A CN 1651088 A CN1651088 A CN 1651088A CN 200410021760 CN200410021760 CN 200410021760 CN 200410021760 A CN200410021760 A CN 200410021760A CN 1651088 A CN1651088 A CN 1651088A
- Authority
- CN
- China
- Prior art keywords
- effervescent
- sugar alcohol
- acid
- agent
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000005846 sugar alcohols Chemical class 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims description 27
- 229920001223 polyethylene glycol Polymers 0.000 title description 4
- 239000004615 ingredient Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 27
- 230000000694 effects Effects 0.000 claims description 22
- 239000008187 granular material Substances 0.000 claims description 17
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 16
- 229930195725 Mannitol Natural products 0.000 claims description 16
- 239000000594 mannitol Substances 0.000 claims description 16
- 235000010355 mannitol Nutrition 0.000 claims description 16
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 14
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 14
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 14
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 14
- 239000000600 sorbitol Substances 0.000 claims description 14
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 13
- 239000000796 flavoring agent Substances 0.000 claims description 13
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 13
- 239000000811 xylitol Substances 0.000 claims description 13
- 235000010447 xylitol Nutrition 0.000 claims description 13
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 13
- 229960002675 xylitol Drugs 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 239000002671 adjuvant Substances 0.000 claims description 11
- 235000015165 citric acid Nutrition 0.000 claims description 11
- 239000002552 dosage form Substances 0.000 claims description 11
- 235000013355 food flavoring agent Nutrition 0.000 claims description 11
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 10
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 10
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 10
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 10
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 10
- 239000008101 lactose Substances 0.000 claims description 10
- 150000007524 organic acids Chemical class 0.000 claims description 10
- 239000007884 disintegrant Substances 0.000 claims description 9
- 229940079593 drug Drugs 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 9
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 7
- -1 hydroxyl isomaltulose Chemical compound 0.000 claims description 7
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 6
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 claims description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 6
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 5
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-threitol Chemical compound OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 claims description 5
- 239000004386 Erythritol Substances 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 235000009508 confectionery Nutrition 0.000 claims description 5
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 5
- 235000019414 erythritol Nutrition 0.000 claims description 5
- 229940009714 erythritol Drugs 0.000 claims description 5
- 239000001630 malic acid Substances 0.000 claims description 5
- 235000011090 malic acid Nutrition 0.000 claims description 5
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 3
- 239000001361 adipic acid Substances 0.000 claims description 3
- 235000011037 adipic acid Nutrition 0.000 claims description 3
- 239000001530 fumaric acid Substances 0.000 claims description 3
- 235000011087 fumaric acid Nutrition 0.000 claims description 3
- 239000000174 gluconic acid Substances 0.000 claims description 3
- 235000012208 gluconic acid Nutrition 0.000 claims description 3
- 239000004310 lactic acid Substances 0.000 claims description 3
- 235000014655 lactic acid Nutrition 0.000 claims description 3
- 238000005457 optimization Methods 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 239000011736 potassium bicarbonate Substances 0.000 claims description 3
- 229910000028 potassium bicarbonate Inorganic materials 0.000 claims description 3
- 235000015497 potassium bicarbonate Nutrition 0.000 claims description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 3
- 235000011181 potassium carbonates Nutrition 0.000 claims description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 235000017550 sodium carbonate Nutrition 0.000 claims description 3
- 239000011975 tartaric acid Substances 0.000 claims description 3
- 235000002906 tartaric acid Nutrition 0.000 claims description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 claims 1
- 239000000306 component Substances 0.000 claims 1
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 20
- 239000003826 tablet Substances 0.000 description 13
- 230000006870 function Effects 0.000 description 10
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- 235000017557 sodium bicarbonate Nutrition 0.000 description 10
- 239000000470 constituent Substances 0.000 description 9
- 238000001035 drying Methods 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 5
- 239000007779 soft material Substances 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 235000015218 chewing gum Nutrition 0.000 description 4
- 229940112822 chewing gum Drugs 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- HZVFRKSYUGFFEJ-YVECIDJPSA-N (2r,3r,4s,5r)-7-phenylhept-6-ene-1,2,3,4,5,6-hexol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=CC1=CC=CC=C1 HZVFRKSYUGFFEJ-YVECIDJPSA-N 0.000 description 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 2
- 244000099147 Ananas comosus Species 0.000 description 2
- 235000007119 Ananas comosus Nutrition 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 101000801619 Homo sapiens Long-chain-fatty-acid-CoA ligase ACSBG1 Proteins 0.000 description 2
- 102100033564 Long-chain-fatty-acid-CoA ligase ACSBG1 Human genes 0.000 description 2
- 240000008790 Musa x paradisiaca Species 0.000 description 2
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 238000010669 acid-base reaction Methods 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 235000010634 bubble gum Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 241000609240 Ambelania acida Species 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000000419 Chronic Hepatitis B Diseases 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019759 Hepatitis chronic persistent Diseases 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003212 lipotrophic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 125000003071 maltose group Chemical group 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
An effervescent medicine using sugar alcohol as its functional component is disclosed.
Description
Technical field
The present invention relates to sugar alcohol as the application of effective component in the preparation effervescent, also relate to the effervescent of sugar alcohol as effective component.
Background technology
Sugar alcohol belongs to polyhydric alcohol, and at occurring in nature, xylitol extensively is present in various fruit, the vegetable, be a kind of sweeting agent of natural health, but content is very low.The commodity sugar alcohol is to make raw material with agricultural crops such as corn cob, bagasse, makes through deep processing.Also available corresponding monosaccharide of sugar alcohol or disaccharidase reduction generate, as the reducible generation sorbitol of glucose, and the reducible generation maltose alcohol of maltose, the reducible generation mannitol of fructose etc.
Sugar alcohol is not only sweeting agent, also not only has nutritive value, still has wonderful medical functions and health-care effect.
The sugar alcohol heat is low, only can slowly be absorbed in vivo or the part be utilized, can be used as diabetes patient's sweeting agent, supplementary and auxiliary therapeutical agent; Sugar alcohol can promote liver glycogen synthetic, and the liver function of improvement and lipotropic effect are arranged, and treats B-mode chronic persistent hepatitis, and chronic hepatitis B and liver cirrhosis have obvious curative effects, are hepatitis concurrent disease patient's desirable ancillary drugs; Sugar alcohol can not be produced the bacterial fermentation utilization of dental caries in the oral cavity, can suppress the generation of streptococcus growth and acid, so sugar alcohol can prevent anti-caries; Sugar alcohol also has weight losing function.Also have report, sugar alcohol is to otitis media, even sinusitis has the effect of prevention even auxiliary treatment.
Because its good effect, sugar alcohol is widely used in fields such as food, medicine, light industry.
In preparation, sugar alcohol is used on a small quantity as excipient, to improve the physical behavior of dosage form.
(medicine) and the health food that with the sugar alcohol are effective component can have different dosage form, as tablet, electuary, oral liquid etc.At present existing oral liquid, chewing gum etc.Though tablet is taken, preservation and easy to carry, absorb not as liquid agent.Though it is also convenient that oral fluid agent absorbs easily, uses, and preserves and carry existing problems.Electuary can be avoided its defective, is reasonable dosage form.But comparatively speaking, effervescent then has more advantage.The characteristics of effervescent have excellent characteristics: 1) dissolving is fast, and when contacting with water, acid-base reaction produces carbon dioxide, dissolves in very short time; 2) taking convenience, effervescent can produce the effervescent solution that contains active ingredient, and suitable child, old people and the solid preparation crowd that is difficult for swallowing use; 3) bioavailability height, because exist with liquid agent in short-term, medicine active ingredient time in water is very short, unlikely decomposition failure makes drug effect rapid, the bioavailability height; 4) easy to carry, especially than convenient with liquid agent.And effervescent has good perception effect.
The dosage form of sugar alcohol, existing at present oral liquid, chewing gum etc., it is the effervescent of effective component that Shang Weijian has with the sugar alcohol.
Summary of the invention
In view of effervescent as a kind of in collection sense organ, biological utilisation, preservation, use, convenient all good dosage form, again in view of sugar alcohol excellent drug, effect, be that the effective component preparation is a kind of good mode at effervescent with the sugar alcohol.
The inventor notices that patent application is disclosed as 1167436 " low pressure effervescent tablet ", wherein includes maltose alcohol, Sorbitol, mannitol, lactose, xylitol.But these sugar alcohols are not as effective component, but use as the excipient composition.The purpose of this application is to wish to solve the technology difficult problem of low-pressure compacting effervescent tablet, proposes with sugar alcohol as a kind of excipient, to satisfy the needs of low-pressure tabletting.These characteristics have been done to offer some clarification at Instructions Page 2, and original text is " following preparation of the present invention to be explained in more detail.Described preparation solvent is selected from maltose alcohol, Sorbitol, maltose, trehalose, mannitol, lactose and xylitol.These materials have the character of the required excipient of typical effervescent formulation, i.e. highly dissoluble in (1) water, and (2) sense of taste is good, and (3) handle (good flowability and agent of low hygroscopicity) easily, or the like.In addition, these chemical compounds can give tablet above-mentioned fabulous character." " described concrete component can partly or entirely replace being conventionally used as the purification sucrose of excipient ".Also done clearly explanation " be maltose alcohol with a small amount of excipient in the above-mentioned prescribed limit under the low pressure that is meeting the demands, Sorbitol, maltose, trehalose, mannitol, lactose and xylitol prepare " at the description page 5.Another purpose of this application has also illustrated this problem, i.e. this application provides vitamin low pressure effervescent formulation, also promptly prepares the prepared vitamin effervescent formulation of effervescent according to low pressure.
Other has a small amount of patent application, also is that the sugar alcohol with individual species uses as excipient.
The present invention then is to be effective component with the sugar alcohol, and is not only different with above-mentioned patent application purpose, and technical scheme also is different.
First purpose of the present invention provides with sugar alcohol as the application of effective component in the preparation effervescent.
Another object of the present invention provides with the effervescent of sugar alcohol as effective component.
For achieving the above object, the present invention at first provide with sugar alcohol as effective component in the application of preparation in the effervescent.
Application of the present invention, its technical scheme are to include one or more sugar alcohols, gas-producing disintegrant in the described effervescent.
Application of the present invention, described gas-producing disintegrant includes: one or more edible carbonate, one or more edible organic acids.
The preferred sodium bicarbonate of described edible carbonate, sodium carbonate, potassium bicarbonate, potassium carbonate.
Described edible organic acid optimization citric acid, malic acid, tartaric acid, lactic acid, fumaric acid, gluconic acid, adipic acid.
Application of the present invention, the basic ratio of effervescent is sugar alcohol 5%-95%, edible carbonate 3%-45%, edible organic acid 2%-40%.
Application of the present invention, the content of sugar alcohol is preferably 20%-80% in the effervescent.
Application of the present invention is characterized in that also can being used other drug composition, effective component on the basis of sugar alcohol, gas-producing disintegrant, and excipient, adjuvant, sweeting agent, the flavoring agent that can use acceptable routine on the preparation.
Described other drug composition, effective component are meant pharmaceutical compositions, the effective component of non-sugar alcohol, can be the effective components as medicine; It also can be effective component as health product; It can also be function composition as drink with function.Described other drug composition, effective component can be selected for use as required, also can not select for use.
Described figuration composition and adjuvant, be meant adopt conventional as on the preparation of effervescent or the figuration composition and the adjuvant that use on the dosage form, these figuration compositions and adjuvant are known, as lubricant, wetting agent, binding agent, antiseptic etc., concrete as starch, sucrose, lactose, hydroxypropyl cellulose, polyvinylpyrrolidone, Polyethylene Glycol, ethanol etc.These excipient can be selected different kinds for use as required with adjuvant, as feasible on the preparation, also can not select for use.
Described sweeting agent is the sweeting agent of galenic pharmacy and bromatology notion, refers to give the synthetic or native compound of sweet taste, as stevioside, glucide, Aspartane, glycyrrhizin etc.These sweeting agents can be selected for use as required, also can not select for use.
Described flavoring agent also is known, can be acceptable composition on any biology, on the galenic pharmacy.Flavoring agent also can comprise essence (flavouring agent), as flavoring orange essence, flavoring banana essence, Fructus Myricae rubrae essence, Fructus Citri Limoniae essence, flavoring pineapple essence, vanilla, cream flavour, chocolate essence etc.
Application of the present invention, described sugar alcohol can be the sugar alcohol of any kind of, mainly contains xylitol, Sorbitol (sorbitol), mannitol, maltose alcohol, hydroxyl isomaltulose, erythritol, threitol, lactose, Palatinitol benzylidene sorbitol etc.
Application of the present invention, the preferred xylitol of described sugar alcohol, Sorbitol, mannitol, maltose alcohol, hydroxyl isomaltulose, erythritol, threitol, lactose.
Application of the present invention, described effervescent can be the effervescents as medicine.
Application of the present invention, described effervescent can be the effervescents as health product.
Application of the present invention, described effervescent can be the effervescents as drink with function.
Application of the present invention, described effect can be the effects as medicine.
Application of the present invention, described effect can be the effects as health product.
Application of the present invention, described effect can be the effects as drink with function.
Application of the present invention, described effervescent can be effervescent dosage forms feasible on any preparation.
Application of the present invention, described effervescent is a preferred tablet.
Application of the present invention, described effervescent are the preferred particulates agent.
Application of the present invention, described effervescent are preferred electuaries.
Application of the present invention, described effervescent are preferred powder.
Application of the present invention, described effervescent are preferred dry-eating agent.Described dry-eating agent is to soak, and directly takes direct blistered effervescent in mouth.
Application of the present invention, described effervescent are preferred confection forms.
Application of the present invention, described dry-eating agent is a tablet.
Application of the present invention, described dry-eating agent is a granule.
Application of the present invention, described dry-eating agent is a powder.
Application of the present invention, described dry-eating agent is the confection form.
Application of the present invention, described dry-eating agent is a bubble gum.
Application of the present invention, described dry-eating agent is a chewing gum.
For achieving the above object, the invention provides with the effervescent of sugar alcohol as effective component.
Technical scheme of the present invention is with the effervescent of sugar alcohol as effective component, to it is characterized in that including in the described effervescent one or more sugar alcohols, gas-producing disintegrant.
Effervescent of the present invention, described gas-producing disintegrant includes: one or more edible edible carbonate, one or more edible organic acids.
The preferred sodium bicarbonate of described edible carbonate, sodium carbonate, potassium bicarbonate, potassium carbonate.
Described edible organic acid optimization citric acid, malic acid, tartaric acid, lactic acid, fumaric acid, gluconic acid, adipic acid.
Effervescent of the present invention, the basic ratio of effervescent is sugar alcohol 5%-95%, edible carbonate 3%-45%, edible organic acid 2%-40%.
Effervescent of the present invention, the content of sugar alcohol is preferably 20%-80% in the effervescent.
Effervescent of the present invention is characterized in that also can being used other drug composition, effective component on the basis of sugar alcohol, gas-producing disintegrant, and excipient, adjuvant, sweeting agent, the flavoring agent that can use acceptable routine on the preparation.
Described other drug composition, effective component are meant pharmaceutical compositions, the effective component of non-sugar alcohol, can be the effective components as medicine; It also can be effective component as health product; It can also be function composition as drink with function.Described other drug composition, effective component can be selected for use as required, also can not select for use.
Described figuration composition and adjuvant, be meant adopt conventional as on the preparation of effervescent or the figuration composition and the adjuvant that use on the dosage form, these figuration compositions and adjuvant are known, as lubricant, wetting agent, binding agent, antiseptic etc., concrete as starch, sucrose, lactose, hydroxypropyl cellulose, polyvinylpyrrolidone, Polyethylene Glycol, ethanol etc.These excipient can be selected different kinds for use as required with adjuvant, as feasible on the preparation, also can not select for use.
Described sweeting agent is the sweeting agent of galenic pharmacy and bromatology notion, refers to give the synthetic or native compound of sweet taste, as stevioside, glucide, Aspartane, glycyrrhizin etc.These sweeting agents can be selected for use as required, also can not select for use.
Described flavoring agent also is known, can be acceptable composition on any biology, on the galenic pharmacy.Flavoring agent also can comprise essence (flavouring agent), as flavoring orange essence, flavoring banana essence, Fructus Myricae rubrae essence, Fructus Citri Limoniae essence, flavoring pineapple essence, vanilla, cream flavour, chocolate essence etc.
Effervescent of the present invention, described sugar alcohol can be the sugar alcohol of any kind of, mainly contains xylitol, Sorbitol (sorbitol), mannitol, maltose alcohol, hydroxyl isomaltulose, erythritol, threitol, lactose, Palatinitol benzylidene sorbitol etc.
Effervescent of the present invention, the preferred xylitol of described sugar alcohol, Sorbitol, mannitol, maltose alcohol, hydroxyl isomaltulose, erythritol, threitol, lactose.
Effervescent of the present invention, described effervescent can be the effervescents as medicine.
Effervescent of the present invention, described effervescent can be the effervescents as health product.
Effervescent of the present invention, described effervescent can be the effervescents as drink with function.
Effervescent of the present invention, described effect can be the effects as medicine.
Effervescent of the present invention, described effect can be the effects as health product.
Effervescent of the present invention, described effect can be the effects as drink with function.
Effervescent of the present invention, described effervescent can be effervescent dosage forms feasible on any preparation.
Effervescent of the present invention, described effervescent is a preferred tablet.
Effervescent of the present invention, described effervescent are the preferred particulates agent.
Effervescent of the present invention, described effervescent are preferred electuaries.
Effervescent of the present invention, described effervescent are preferred powder.
Effervescent of the present invention, described effervescent are preferred dry-eating agent.Described dry-eating agent is to soak, and directly takes direct blistered effervescent in mouth.
Effervescent of the present invention, described effervescent are preferred confection forms.
Effervescent of the present invention, described dry-eating agent is a tablet.
Effervescent of the present invention, described dry-eating agent is a granule.
Effervescent of the present invention, described dry-eating agent is a powder.
Effervescent of the present invention, described dry-eating agent is the confection form.
Effervescent of the present invention, described dry-eating agent is a bubble gum.
Effervescent of the present invention, described dry-eating agent is a chewing gum.
Of the present invention with the effervescent of sugar alcohol as effective component, its preparation technology is a common process, specifically is divided into two class methods: direct preparation method and branch component preparation method.
1, direct preparation method:
1) whole supplementary materials are sieved, mesh size is 0.5-1.0mm;
2) mixing;
3) drying;
A, directly be packaged into pouch (1 dose every bag amount), be packaged into sack, make powder.
B, add a little binder or wetting agent, not cause acid-base reaction be advisable (binding agent is selected hydroxypropyl cellulose for use, and wetting agent is preferably selected ethanol or Polyethylene Glycol for use);
A) make granule, drying, be packaged into pouch, make granule.
B) compacting makes tablet in flakes.
1, divides the component preparation method
Adopt acid, alkaline constituents to prepare granule or powder respectively, be mixed with the dosage form that becomes to need then.
Be specially:
1) preparation of acid constituents: the sugar alcohol with 1/2, edible organic acid (as citric acid), excipient (can), flavoring agent (can), make soft material with ethanol, granulate drying.
2) preparation of alkaline constituents: the sugar alcohol with 1/2, edible carbonate (as sodium bicarbonate), excipient (can), flavoring agent (can), make soft material with ethanol, granulate;
3) with two component particles mix homogeneously:
A, drying, spray into essence (can), make effervescent granule, can be used as powder or electuary.
B, tabletting make tablet, can be used as the bubble potus, also are available as the dry-eating agent.
The specific embodiment
The invention provides but be not limited to following examples
Embodiment 1
Maltose alcohol 700g, citric acid 120g, sodium bicarbonate 180g mixes maltose alcohol 350g with citric acid; 350g mixes with sodium bicarbonate in addition.
Acid constituents and alkaline constituents are made soft material with ethanol respectively, granulate.
With two component particles mix homogeneously:
A, drying spray into flavoring orange essence, make effervescent granule, can be used as powder or electuary.
B, adding flavoring orange essence, tabletting makes tablet, can be used as the bubble potus, also is available as the dry-eating agent.
Embodiment 2
Xylitol 400g, mannitol 300g, citric acid 60g, malic acid 60g, sodium bicarbonate 180g divides equally bisection with xylitol and mannitol, and 350g xylitol and mannitol (mixing sugar alcohol) mix with citric acid and malic acid; 350g mixes with sodium bicarbonate in addition.
Acid constituents and alkaline constituents are made soft material with ethanol respectively, granulate.
With two component particles mix homogeneously:
A, drying spray into flavoring orange essence, make effervescent granule, can be used as powder or electuary.
B, adding flavoring orange essence, tabletting makes tablet, can be used as the bubble potus, also is available as the dry-eating agent.
Embodiment 3
Sorbitol 300g, mannitol 400g, citric acid 120g, sodium bicarbonate 180g divides equally bisection with Sorbitol and mannitol, and 350g Sorbitol and mannitol (mixing sugar alcohol) mix with citric acid; 350g mixes with sodium bicarbonate in addition.
Acid constituents and alkaline constituents are made soft material with ethanol respectively, granulate.
With two component particles mix homogeneously:
A, drying spray into flavoring orange essence, make effervescent granule, can be used as powder or electuary.
B, adding flavoring orange essence, tabletting makes tablet, can be used as the bubble potus, also is available as the dry-eating agent.
Embodiment 4
Xylitol 400g, mannitol 300g, citric acid 120g, sodium bicarbonate 180g.Whole supplementary materials are sieved, and mesh size is 0.5mm; Mixing; Dry:
A, directly be packaged into pouch (1 dose every bag amount), be packaged into sack, make powder.
B, add a little binder hydroxypropyl cellulose:
A) make granule, drying, be packaged into pouch, make granule.
B) compacting makes tablet in flakes.
Claims (10)
1, sugar alcohol is as the application of effective component in the preparation effervescent.
2, according to the application of claim 1, the content that it is characterized in that sugar alcohol in the effervescent is 5%-95%.
3,, it is characterized in that the content of sugar alcohol is preferably 20%-80% in the effervescent according to the application of claim 1.
4, be the effervescent of effective component with the sugar alcohol, it is characterized in that including in the described effervescent one or more sugar alcohols, gas-producing disintegrant.
5,, it is characterized in that described gas-producing disintegrant includes: one or more edible carbonate, one or more edible organic acids according to the effervescent of claim 4.Described edible carbonate, preferred sodium bicarbonate, sodium carbonate, potassium bicarbonate, potassium carbonate; Described edible organic acid optimization citric acid, malic acid, tartaric acid, lactic acid, fumaric acid, gluconic acid, adipic acid.
6,, it is characterized in that basic ratio is sugar alcohol 5%-95%, edible carbonate 3%-45%, edible organic acid 2%-40% according to the effervescent of claim 4.
7, according to claim 4 and 6 arbitrary described effervescents, it is characterized in that on the basis of sugar alcohol, gas-producing disintegrant, also can be used other drug composition, effective component, and excipient, adjuvant, sweeting agent, the flavoring agent that can use acceptable routine on the preparation.
8, according to claim 4,6,7 arbitrary described effervescents, it is characterized in that the preferred xylitol of described sugar alcohol, Sorbitol, mannitol, maltose alcohol, hydroxyl isomaltulose, erythritol, threitol, lactose.
9, according to claim 4,6,7 arbitrary described effervescents, it is characterized in that described effervescent can be as medicine effervescent, as the effervescent of health product, as the effervescent of drink with function.Described effect can be as medicine effect, as the effect of health product, as the effect of drink with function.
10,, it is characterized in that described effervescent can be an effervescent dosage form feasible on any preparation, preferred tablet, granule, electuary, powder, dry-eating agent, confection form according to claim 4,6,7 arbitrary described effervescents.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410021760 CN1651088A (en) | 2004-02-04 | 2004-02-04 | Effervescent preparation using alditol as functional ingredient |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410021760 CN1651088A (en) | 2004-02-04 | 2004-02-04 | Effervescent preparation using alditol as functional ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1651088A true CN1651088A (en) | 2005-08-10 |
Family
ID=34868359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410021760 Pending CN1651088A (en) | 2004-02-04 | 2004-02-04 | Effervescent preparation using alditol as functional ingredient |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1651088A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966165A (en) * | 2009-07-14 | 2011-02-09 | 无锡健而乐医药科技有限公司 | Solid effervescent mixture for the oral absorption |
| CN103446166A (en) * | 2012-05-29 | 2013-12-18 | 上野制药株式会社 | Liver function-improving agent |
| CN103892399A (en) * | 2014-04-12 | 2014-07-02 | 曲阜圣香远生物科技有限公司 | Stevioside effervescent tablet suitable for diabetes patients |
| CN103919108A (en) * | 2014-04-12 | 2014-07-16 | 曲阜圣香远生物科技有限公司 | Method for preparing stevia sugar effervescent tablets suitable for diabetic patients to eat |
| CN104306971A (en) * | 2014-10-29 | 2015-01-28 | 张树超 | Medicine composition for resisting cervical cancer with matching of photodynamic therapy |
| CN107875393A (en) * | 2016-09-30 | 2018-04-06 | 深圳市傲来大健康产业有限公司 | A kind of lozenge flavouring and preparation method thereof |
| JP2018183067A (en) * | 2017-04-24 | 2018-11-22 | 株式会社松原製餡所 | Expandable additive and bean jam food product |
| JP2020158431A (en) * | 2019-03-26 | 2020-10-01 | 物産フードサイエンス株式会社 | Gas generation inhibitor, method for producing effervescent composition and effervescent composition |
| JP2022553004A (en) * | 2019-10-17 | 2022-12-21 | アイエスピー インヴェストメンツ エルエルシー | Stable effervescent co-processed excipient compositions and methods for their preparation |
-
2004
- 2004-02-04 CN CN 200410021760 patent/CN1651088A/en active Pending
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101966165A (en) * | 2009-07-14 | 2011-02-09 | 无锡健而乐医药科技有限公司 | Solid effervescent mixture for the oral absorption |
| CN101966165B (en) * | 2009-07-14 | 2012-06-13 | 无锡健而乐医药科技有限公司 | Solid effervescent mixture for the oral absorption |
| CN103446166A (en) * | 2012-05-29 | 2013-12-18 | 上野制药株式会社 | Liver function-improving agent |
| CN103446166B (en) * | 2012-05-29 | 2017-06-13 | 上野制药株式会社 | Hepatic function remedial agent |
| CN103919108A (en) * | 2014-04-12 | 2014-07-16 | 曲阜圣香远生物科技有限公司 | Method for preparing stevia sugar effervescent tablets suitable for diabetic patients to eat |
| CN103892399B (en) * | 2014-04-12 | 2015-03-18 | 曲阜圣香远生物科技有限公司 | Stevioside effervescent tablet suitable for diabetes patients |
| CN103919108B (en) * | 2014-04-12 | 2015-04-01 | 曲阜圣香远生物科技有限公司 | Method for preparing stevia sugar effervescent tablets suitable for diabetic patients to eat |
| CN103892399A (en) * | 2014-04-12 | 2014-07-02 | 曲阜圣香远生物科技有限公司 | Stevioside effervescent tablet suitable for diabetes patients |
| CN104306971A (en) * | 2014-10-29 | 2015-01-28 | 张树超 | Medicine composition for resisting cervical cancer with matching of photodynamic therapy |
| CN107875393A (en) * | 2016-09-30 | 2018-04-06 | 深圳市傲来大健康产业有限公司 | A kind of lozenge flavouring and preparation method thereof |
| CN107875393B (en) * | 2016-09-30 | 2021-05-18 | 深圳市傲来大健康产业有限公司 | Buccal tablet flavoring agent and preparation method thereof |
| JP2018183067A (en) * | 2017-04-24 | 2018-11-22 | 株式会社松原製餡所 | Expandable additive and bean jam food product |
| JP2020158431A (en) * | 2019-03-26 | 2020-10-01 | 物産フードサイエンス株式会社 | Gas generation inhibitor, method for producing effervescent composition and effervescent composition |
| JP7071941B2 (en) | 2019-03-26 | 2022-05-19 | 物産フードサイエンス株式会社 | Gas generation inhibitor, method for producing effervescent composition and effervescent composition |
| JP2022553004A (en) * | 2019-10-17 | 2022-12-21 | アイエスピー インヴェストメンツ エルエルシー | Stable effervescent co-processed excipient compositions and methods for their preparation |
| EP4045008A4 (en) * | 2019-10-17 | 2023-11-15 | ISP Investments LLC | A stable effervescent co-processed excipient composition and a process for preparing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1234230A (en) | chewable products | |
| CN1651088A (en) | Effervescent preparation using alditol as functional ingredient | |
| CN1136274A (en) | New pharmaceutical composition for the preparation of stable powders containing as main active ingredients an association of acetylsalicylic acid and metoclopramide | |
| CN1698663A (en) | Ring form effervescence dosage and preparation method thereof | |
| CN1857264A (en) | Medicine composition with pioglitazone hydrochloride and glimepiride as active components and its preparing method and use | |
| CN1292756C (en) | Effervescence tablet preparation for replenishing nutritious elements to human being and its preparation method | |
| CN1742957A (en) | Sangju effervescent tablet for treating common cold | |
| CN1778293A (en) | Rutin effervesce agent composition | |
| CN1293831C (en) | Effervescent solid beverage of amino acid chelated calcium and its prepn | |
| CN1943594A (en) | Oral disintegrating tablet of lysine calcium mono hydrogen phosphate | |
| CN1650884A (en) | Effervescent agent using medium glycan or/and polysaccharide dief fiber as functional component | |
| CN1235577C (en) | Products using L-arginine as raw materials | |
| CN1634096A (en) | Notoginseng total saponin orally disintegrating tablet | |
| CN1939423A (en) | Rhizoma corydalis analgetic dispersing tablet | |
| CN1939399A (en) | Blood stream-breaking dispersing tablets | |
| CN1939512A (en) | Infantile overfood dispersing tablets | |
| CN1939449A (en) | Infantile heat-clearing and antitussive dispersing tablets | |
| CN100336505C (en) | Soybean aglycone soft capsule and its preparing method | |
| CN1296045C (en) | Oral disintegration tablet of dihydroergotoxine and its derivatives and its preparing process | |
| CN1634083A (en) | Orally disintegrating tablet of aspirin | |
| CN1823795A (en) | Medicinal composition for treating diabetes and its preparation method | |
| CN1682973A (en) | A stepahin orally disintegrating tablet and preparation method thereof | |
| CN1698644A (en) | Ribavirin orally disintegrating tablet and preparation method thereof | |
| CN1291510A (en) | Health-care or medicinal tablet containing active ganoderma extract | |
| CN1939430A (en) | Yiqing dispersing tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20050810 |